Literature DB >> 16952367

COX-1 and COX-2 expression in feline oral squamous cell carcinoma.

A Hayes1, T Scase2, J Miller2, S Murphy2, A Sparkes2, V Adams2.   

Abstract

This study demonstrated immunohistochemically the expression of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) in feline oral squamous cell carcinoma (FOSCC), with primary polyclonal antibodies raised against human epitopes. COX-2 immunolabelling was intracytoplasmic and, in some neoplastic cells, perinuclear; it was demonstrated in a small proportion (< or = 1%) of neoplastic cells and its intensity was usually mild to moderate. In contrast, all neoplastic tissues showed extensive nuclear and cytoplasmic COX-1 immunolabelling. Cytoplasmic COX-1 immunolabelling was less intense than nuclear labelling in neoplastic tissue. In the adjacent histologically normal oral mucosa, COX-2 immunolabelling was absent. The cytoplasmic and nuclear intensity and distribution of COX-1 immunolabelling was significantly higher in neoplastic tissue than in adjacent normal oral mucosa. The results indicate that COX-1 and COX-2 are overexpressed in FOSCC, but the clinical and pathophysiological significance of this finding remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952367     DOI: 10.1016/j.jcpa.2006.06.001

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  12 in total

1.  Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

Authors:  C K Martin; W P Dirksen; M M Carlton; L G Lanigan; S P Pillai; J L Werbeck; J K Simmons; B E Hildreth; C A London; R E Toribio; T J Rosol
Journal:  Vet Comp Oncol       Date:  2013-05-08       Impact factor: 2.613

2.  New diagnostic markers in salivary gland tumors.

Authors:  Sven Schneider; Philipp Kloimstein; Johannes Pammer; Werner Brannath; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-04       Impact factor: 2.503

3.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

4.  Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus).

Authors:  Dale Buchanan Hales; Yan Zhuge; Jo Ann Jaen Lagman; Kristine Ansenberger; Cassandra Mahon; Animesh Barua; Judith L Luborsky; Janice M Bahr
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

5.  Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.

Authors:  H Yoshikawa; E J Ehrhart; J B Charles; J T Custis; S M LaRue
Journal:  Vet Comp Oncol       Date:  2013-07-02       Impact factor: 2.613

Review 6.  Cats, Cancer and Comparative Oncology.

Authors:  Claire M Cannon
Journal:  Vet Sci       Date:  2015-06-30

7.  Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma.

Authors:  Hunter John Piegols; Marilia Takada; Maciej Parys; Thomas Dexheimer; Vilma Yuzbasiyan-Gurkan
Journal:  Oncotarget       Date:  2018-09-04

8.  Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.

Authors:  Elizabeth A Ballegeer; Nicole J Madrill; Kevin L Berger; Dalen W Agnew; Elizabeth A McNiel
Journal:  BMC Cancer       Date:  2013-04-30       Impact factor: 4.430

9.  Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney.

Authors:  L Pelligand; N Suemanotham; J N King; W Seewald; H Syme; K Smith; P Lees; J Elliott
Journal:  BMC Vet Res       Date:  2015-12-03       Impact factor: 2.741

10.  Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma.

Authors:  Jorge Castro-López; Antonio Ramis; Marta Planellas; Mariana Teles; Josep Pastor
Journal:  BMC Vet Res       Date:  2018-05-15       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.